Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Apr 26, 2022; 14(4): 303-309
Published online Apr 26, 2022. doi: 10.4252/wjsc.v14.i4.303
Treatment of syringomyelia using uncultured umbilical cord mesenchymal stem cells: A case report and review of literature
Hyunjun Ahn, Sang Yeon Lee, Won-Ju Jung, Kye-Ho Lee
Hyunjun Ahn, Sang Yeon Lee, Kye-Ho Lee, Stem Cell Treatment and Research Institute (STRI), bio Beauty and Health Company (bBHC), Seoul 04420, South Korea
Won-Ju Jung, Stem Cell Treatment, 97.7 Beauty and Health Clinic, Seoul 04420, South Korea
Author contributions: Ahn H, Lee SY, Jung WJ, and Lee KH designed the report; Ahn H and Jung WJ collected the patient’s clinical data; Ahn H, Lee SY, and Jung WJ analyzed the data; Ahn H wrote the manuscript; Lee KH provided professional advice and revised the manuscript; All authors issued final approval for the version to be submitted.
Informed consent statement: The patient involved in this study gave her written informed consent authorizing disclosure of her protected health information.
Conflict-of-interest statement: All authors have no conflicts of interest to declare.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kye-Ho Lee, PhD, Stem Cell Treatment and Research Institute (STRI), bio Beauty and Health Company (bBHC), No. 72 UN Village-gil, Yongsan-gu, Seoul 04420, South Korea. khlee@stc365.com
Received: December 13, 2021
Peer-review started: December 13, 2021
First decision: January 30, 2022
Revised: February 28, 2022
Accepted: March 26, 2022
Article in press: March 26, 2022
Published online: April 26, 2022
Processing time: 134 Days and 13.8 Hours
Core Tip

Core Tip: Syringomyelia has no suitable treatment other than surgical methods, but these methods carry the possibility of failure, recurrence, and side effects. In this study, we treated a patient with syringomyelia using uncultured umbilical cord-derived mesenchymal stem cells. This method could be a new treatment alternative for syringomyelia.